Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (91-100 of 211) with videos related to

Pageof 22
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancerJ B Sørensen, L E Stenbygaard, P Dombernowsky, et al.
The New England Journal of Medicine|April 15, 1993
Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapyJ Herrstedt, T Sigsgaard, M Boesgaard, et al.
Cancer Treatment Reports|February 1, 1982
Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lungK Osterlind, S Hørbov, P Dombernowsky, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a reviewN I Nissen, P Dombernowsky, H H Hansen, et al.
Seminars in Oncology|October 1, 1996
Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancerP Dombernowsky, J Gehl, M Boesgaard, et al.
Thorax|April 1, 1985
Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patientsK Osterlind, M Hansen, H H Hansen, et al.
Cancer Treatment Reports|April 1, 1980
CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal womenM Salimtschik, S Snel, H Havsteen, et al.
Cancer Treatment Reports|January 1, 1981
5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trialH Havsteen, S Sörenson, M Rørth, et al.
Ugeskrift for Laeger|October 6, 1980
[Cytostatic chemotherapy and radiotherapy in small cell anaplastic lung carcinoma. Results of 2 prospective studies]H H Hansen, P Dombernowsky, M Hansen, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
The value of yearly chest X-ray in patients with stage I breast cancerA Vestergaard, J Herrstedt, H S Thomsen, et al.
Pageof 22

Showing results (91-100 of 211) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancerJ B Sørensen, L E Stenbygaard, P Dombernowsky, et al.
The New England Journal of Medicine|April 15, 1993
Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapyJ Herrstedt, T Sigsgaard, M Boesgaard, et al.
Cancer Treatment Reports|February 1, 1982
Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lungK Osterlind, S Hørbov, P Dombernowsky, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a reviewN I Nissen, P Dombernowsky, H H Hansen, et al.
Seminars in Oncology|October 1, 1996
Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancerP Dombernowsky, J Gehl, M Boesgaard, et al.
Thorax|April 1, 1985
Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patientsK Osterlind, M Hansen, H H Hansen, et al.
Cancer Treatment Reports|April 1, 1980
CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal womenM Salimtschik, S Snel, H Havsteen, et al.
Cancer Treatment Reports|January 1, 1981
5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trialH Havsteen, S Sörenson, M Rørth, et al.
Ugeskrift for Laeger|October 6, 1980
[Cytostatic chemotherapy and radiotherapy in small cell anaplastic lung carcinoma. Results of 2 prospective studies]H H Hansen, P Dombernowsky, M Hansen, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
The value of yearly chest X-ray in patients with stage I breast cancerA Vestergaard, J Herrstedt, H S Thomsen, et al.
Pageof 22